Understanding Cell Killing and Resistance in Breast Cancer Chemotherapy
Author Information
Author(s): Ubezio Paolo, Cameron David
Primary Institution: Istituto di Ricerche Farmacologiche 'Mario Negri'
Hypothesis
Can a mathematical model accurately estimate the fraction of cancer cells killed and the proportion that is resistant during pre-operative chemotherapy for breast cancer?
Conclusion
The study successfully developed a mathematical model that provides insights into the effectiveness of chemotherapy on breast cancer cells, highlighting the importance of considering both cycling and quiescent cells.
Supporting Evidence
- The model identified different patterns of response to treatment among patients.
- About half of the patients showed a regular decrease in tumor volume.
- Some patients exhibited a shift to higher sensitivity during therapy.
Takeaway
This study created a math model to see how well chemotherapy works on breast cancer by looking at how many cancer cells are killed and how many resist the treatment.
Methodology
A mathematical model was designed to analyze the time course of tumor volumes in patients undergoing chemotherapy, incorporating measures of cell proliferation.
Limitations
The model's precision could be improved with additional data, particularly sequential measures of Ki67.
Participant Demographics
Patients with large operable breast cancers (stages T2 or T3) receiving preoperative chemotherapy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website